Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization
Abstract No licensed human vaccines are currently available against leishmaniasis. Several anti-leishmanial vaccines are currently undergoing testing, including genetically modified live-attenuated parasite vaccines. Studies with live attenuated Leishmania vaccines such as centrin deleted Leishmania...
Guardado en:
Autores principales: | Sreenivas Gannavaram, John Torcivia, Lusine Gasparyan, Amit Kaul, Nevien Ismail, Vahan Simonyan, Hira L. Nakhasi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d976c0ed5ec047e4a8b50c73f5058f1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
por: Wen-Wei Zhang, et al.
Publicado: (2020) -
Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
por: Subir Karmakar, et al.
Publicado: (2021) -
Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice
por: Guilherme D. Melo, et al.
Publicado: (2017) -
Identification of a secreted casein kinase 1 in Leishmania donovani: effect of protein over expression on parasite growth and virulence.
por: Mary Dan-Goor, et al.
Publicado: (2013) -
Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis.
por: Doumet Georges Helou, et al.
Publicado: (2021)